Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging

The EASL diagnostic algorithm for hepatocellular carcinoma, currently in use, dates back to 2018. While awaiting its update, numerous advancements have emerged in the field of hepatocellular carcinoma imaging. These innovations impact every step of the diagnostic algorithm, from surveillance protoco...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Renzulli, Emanuela Giampalma
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/32/1/40
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588696568725504
author Matteo Renzulli
Emanuela Giampalma
author_facet Matteo Renzulli
Emanuela Giampalma
author_sort Matteo Renzulli
collection DOAJ
description The EASL diagnostic algorithm for hepatocellular carcinoma, currently in use, dates back to 2018. While awaiting its update, numerous advancements have emerged in the field of hepatocellular carcinoma imaging. These innovations impact every step of the diagnostic algorithm, from surveillance protocols to diagnostic processes, encompassing aspects preceding a patient’s inclusion in surveillance programs as well as the potential applications of imaging after the hepatocellular carcinoma diagnosis. Notably, these diagnostic advancements are particularly evident in the domain of magnetic resonance imaging. For example, the sensitivity of ultrasound in diagnosing very early-stage and early-stage hepatocellular carcinoma during the surveillance phase is very low (less than 50%) and a potential improvement in this sensitivity value could be achieved by using abbreviated protocols in magnetic resonance imaging. The aim of this review is to explore the 2024 updates in magnetic resonance imaging for hepatocellular carcinoma, with a focus on its role in surveillance, nodular size assessment, post-diagnosis imaging applications, and its potential role before the initiation of surveillance.
format Article
id doaj-art-59299213d0bf4089a4e8f4eb45cfc1da
institution Kabale University
issn 1198-0052
1718-7729
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj-art-59299213d0bf4089a4e8f4eb45cfc1da2025-01-24T13:28:27ZengMDPI AGCurrent Oncology1198-00521718-77292025-01-013214010.3390/curroncol32010040Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance ImagingMatteo Renzulli0Emanuela Giampalma1Radiology Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, 47122 Forlì, ItalyRadiology Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, 47122 Forlì, ItalyThe EASL diagnostic algorithm for hepatocellular carcinoma, currently in use, dates back to 2018. While awaiting its update, numerous advancements have emerged in the field of hepatocellular carcinoma imaging. These innovations impact every step of the diagnostic algorithm, from surveillance protocols to diagnostic processes, encompassing aspects preceding a patient’s inclusion in surveillance programs as well as the potential applications of imaging after the hepatocellular carcinoma diagnosis. Notably, these diagnostic advancements are particularly evident in the domain of magnetic resonance imaging. For example, the sensitivity of ultrasound in diagnosing very early-stage and early-stage hepatocellular carcinoma during the surveillance phase is very low (less than 50%) and a potential improvement in this sensitivity value could be achieved by using abbreviated protocols in magnetic resonance imaging. The aim of this review is to explore the 2024 updates in magnetic resonance imaging for hepatocellular carcinoma, with a focus on its role in surveillance, nodular size assessment, post-diagnosis imaging applications, and its potential role before the initiation of surveillance.https://www.mdpi.com/1718-7729/32/1/40hepatocellular carcinomamagnetic resonance imagingdiagnostic algorithmsurveillance program
spellingShingle Matteo Renzulli
Emanuela Giampalma
Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
Current Oncology
hepatocellular carcinoma
magnetic resonance imaging
diagnostic algorithm
surveillance program
title Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
title_full Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
title_fullStr Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
title_full_unstemmed Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
title_short Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
title_sort hepatocellular carcinoma imaging advances in 2024 with a focus on magnetic resonance imaging
topic hepatocellular carcinoma
magnetic resonance imaging
diagnostic algorithm
surveillance program
url https://www.mdpi.com/1718-7729/32/1/40
work_keys_str_mv AT matteorenzulli hepatocellularcarcinomaimagingadvancesin2024withafocusonmagneticresonanceimaging
AT emanuelagiampalma hepatocellularcarcinomaimagingadvancesin2024withafocusonmagneticresonanceimaging